Dihydroartemisinin [clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613]
Efficacy and Safety of Dihydroartemisinin/Piperaquine (Artekin®) for the Treatment of Uncomplicated Malaria in Peru [clinicaltrials:NCT00373607]clinicaltrials:NCT00393679clinicaltrials:NCT00527800Three Alternative Drug Regimens for Malaria Seasonal Preventive Treatment in Senegal [clinicaltrials:NCT00529620]clinicaltrials:NCT00682578Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso [clinicaltrials:NCT00845533]Intermittent Preventive Treatment of Malaria in Schoolchildren [clinicaltrials:NCT00852371]clinicaltrials:NCT00852423Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy (TRANSACT) [clinicaltrials:NCT00868465]Dihydroartemisinin (DHA)-Piperaquine for IPT to Prevent Malaria in Children in Burkina Faso [clinicaltrials:NCT00941785]clinicaltrials:NCT00948896clinicaltrials:NCT01038063clinicaltrials:NCT01054248Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in Sudan [clinicaltrials:NCT01075945]Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in Children [clinicaltrials:NCT01082705]Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers [clinicaltrials:NCT01103830]clinicaltrials:NCT01165372A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurartesim™ [clinicaltrials:NCT01222949]clinicaltrials:NCT01231113School Based Malaria Control in Ugandan Schoolchildren [clinicaltrials:NCT01231880]clinicaltrials:NCT01280162Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax Malaria [clinicaltrials:NCT01288820]Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi [clinicaltrials:NCT01326754]Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra [clinicaltrials:NCT01389557]Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases [clinicaltrials:NCT01392014]Pharmacokinetic Study of Primaquine and Dihydroartemisinin-Piperaquine in Healthy Subjects [clinicaltrials:NCT01525511]Comparison Between 7 and 14 Day Primaquine Combined With Dihydroartemisinin-piperaquine or 3 Day Chloroquine Radical Cure of P. Vivax (BPD) [clinicaltrials:NCT01640574]clinicaltrials:NCT01640587clinicaltrials:NCT01651416clinicaltrials:NCT01669941clinicaltrials:NCT01704508Phase2a Primaquine Dose Escalation Study [clinicaltrials:NCT01743820]clinicaltrials:NCT01755559clinicaltrials:NCT01838902Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon [clinicaltrials:NCT01845701]clinicaltrials:NCT01872702clinicaltrials:NCT01878357clinicaltrials:NCT01887821Evaluation of the Efficacy of Artemisinin Combination Therapy in Kenya [clinicaltrials:NCT01899820]clinicaltrials:NCT01930331
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Dihydroartemisinin [clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613]
Bio2RDF identifier
01ff81f4a1524adfdcd1f907fa736613
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613
identifier
clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613
title
Dihydroartemisinin
@en
type
label
Dihydroartemisinin [clinicaltrials_resource:01ff81f4a1524adfdcd1f907fa736613]
@en